Indicated for: HIV-1 infection
Substance: indinavir (protease inhibitor)
ATC: J05AE02 (Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors)
Indinavir is an antiretroviral medication used to treat human immunodeficiency virus (HIV) infection. It belongs to the class of protease inhibitors and works by blocking the HIV protease enzyme, which is essential for viral replication.
The medication is taken orally, usually three times a day, as directed by a doctor.
Side effects may include nausea, abdominal pain, diarrhea, dry mouth, or kidney stone formation. In rare cases, severe allergic reactions or changes in body fat distribution may occur.
Patients should strictly follow the treatment regimen and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.